6533b82efe1ef96bd1292ff2
RESEARCH PRODUCT
Anti-CD20 immunotherapy as a bridge to tolerance, after allogeneic stem cell transplantation for patients with chronic lymphocytic leukaemia: results of the CLLX4 trial
Friedrich StölzelDeutsche Cll StudiengruppeGuido KobbeGernot StuhlerSebastian BöttcherJan Moritz MiddekeKatja SockelEva WagnerKarl-anton KreuzerMichael KramerJohannes ScheteligCornelia S. LinkRaphael TeipelMalte Von BoninMartin BornhäuserStephan StilgenbauerMathias HänelMichael Halleksubject
CD20biologybusiness.industrymedicine.medical_treatmentHematologyImmunotherapyHematopoietic stem cell transplantationmedicine.diseaseOfatumumabTransplantation03 medical and health sciencesLeukemiachemistry.chemical_compound0302 clinical medicinechemistry030220 oncology & carcinogenesisImmunologyMonoclonalbiology.proteinMedicineStem cellbusiness030215 immunologyyear | journal | country | edition | language |
---|---|---|---|---|
2018-03-12 | British Journal of Haematology |